The easiest path to AI for antibody scientists

At EVQLV, we leverage our expertise in machine learning, computational biology, drug development, and software engineering to transform the pace, cost, and scale of antibody discovery. Our proprietary computational platform EVQLVes antibody discovery by generating diverse, fully-human antibodies.

Whether the project is to rescue a failing lead, de novo design and discovery, or design a biodifferent antibody from a known antibody, EVQLV’s technology allows us to work with our partners in a variety of ways. Our technology was built with you in mind, providing the flexibility to solve your specific antibody design challenges.